高级检索
    沈坤炜, 廖宁. 紫杉醇序贯表阿霉素新辅助化疗联合曲妥珠单抗显著提高病理完全缓解率[J]. 循证医学, 2006, 6(2): 84-86. DOI: 10.3969/j.issn.1671-5144.2006.02.006
    引用本文: 沈坤炜, 廖宁. 紫杉醇序贯表阿霉素新辅助化疗联合曲妥珠单抗显著提高病理完全缓解率[J]. 循证医学, 2006, 6(2): 84-86. DOI: 10.3969/j.issn.1671-5144.2006.02.006
    shu
    SHEN Kun-wei, LIAO Ning. Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel,and Epirubicin Chemotherapy[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 84-86. DOI: 10.3969/j.issn.1671-5144.2006.02.006
    Citation: SHEN Kun-wei, LIAO Ning. Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel,and Epirubicin Chemotherapy[J]. Journal of Evidence-Based Medicine, 2006, 6(2): 84-86. DOI: 10.3969/j.issn.1671-5144.2006.02.006
    shu

    紫杉醇序贯表阿霉素新辅助化疗联合曲妥珠单抗显著提高病理完全缓解率

    Significantly Higher Pathologic Complete Remission Rate after Neoadjuvant Therapy with Trastuzumab, Paclitaxel,and Epirubicin Chemotherapy

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回